BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thompson J, Jones N, Al-Khafaji A, Malik S, Reich D, Munoz S, MacNicholas R, Hassanein T, Teperman L, Stein L. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018;24:380-393. [PMID: 29171941 DOI: 10.1002/lt.24986] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Tatum R, Wong D, Martins P, Tchantchaleishvili V. Current status and future directions in the development and optimization of thoracic and abdominal artificial organs. Artificial Organs 2022. [DOI: 10.1111/aor.14458] [Reference Citation Analysis]
2 Nevens F, van der Merwe S. Mesenchymal Stem Cell Transplantation in Liver Diseases. Semin Liver Dis 2022;42:283-92. [PMID: 36049782 DOI: 10.1055/s-0042-1755328] [Reference Citation Analysis]
3 Wakil A, Niazi M, Meybodi MA, Pyrsopoulos NT. Emerging Pharmacotherapies in Alcohol-associated Hepatitis (AH). Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.06.012] [Reference Citation Analysis]
4 Feng L, Wang Y, Liu S, He G, Cai L, Qin J, Xu X, Jiang Z, Zhou C, Gao Y. In vitro safety and efficacy evaluation of a novel hybrid bioartificial liver system with simulated liver failure serum. Int J Artif Organs 2022;:3913988221091286. [PMID: 35416082 DOI: 10.1177/03913988221091286] [Reference Citation Analysis]
5 Pose E, Ginès P. Improving Outcome Prediction in Alcohol-Associated Hepatitis: Blood Urea Nitrogen and Albumin Help. Mayo Clin Proc 2022;97:436-8. [PMID: 35246282 DOI: 10.1016/j.mayocp.2022.01.019] [Reference Citation Analysis]
6 Hernandez JC, Yeh DW, Marh J, Choi HY, Kim J, Chopra S, Ding L, Thornton M, Grubbs B, Makowka L, Sher L, Machida K. Activated and nonactivated MSCs increase survival in humanized mice after acute liver injury through alcohol binging. Hepatol Commun 2022. [PMID: 35246968 DOI: 10.1002/hep4.1924] [Reference Citation Analysis]
7 Gelu-simeon M, Mathurin P. Acute Alcoholic Hepatitis: Indication for Early Liver Transplantation. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_4] [Reference Citation Analysis]
8 Liu WM, Zhou X, Chen CY, Lv DD, Huang WJ, Peng Y, Wu HP, Chen Y, Tang D, Guo LN, Wang XL, Zhang HD, Liu XH, Yang LQ, Yu WF, Yan HX. Establishment of Functional Liver Spheroids From Human Hepatocyte-Derived Liver Progenitor-Like Cells for Cell Therapy. Front Bioeng Biotechnol 2021;9:738081. [PMID: 34858956 DOI: 10.3389/fbioe.2021.738081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ballester MP, Sittner R, Jalan R. Alcohol and Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Reza HA, Okabe R, Takebe T. Organoid transplant approaches for the liver. Transpl Int 2021;34:2031-45. [PMID: 34614263 DOI: 10.1111/tri.14128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Pluta KD, Ciezkowska M, Wisniewska M, Wencel A, Pijanowska DG. Cell-based clinical and experimental methods for assisting the function of impaired livers – Present and future of liver support systems. Biocybernetics and Biomedical Engineering 2021;41:1322-46. [DOI: 10.1016/j.bbe.2021.06.005] [Reference Citation Analysis]
12 Van Melkebeke L, Korf H, Tsochatzis EA, van der Merwe S, Nevens F, Verbeek J. Treatment of severe alcoholic hepatitis: A systematic review. Curr Opin Pharmacol 2021;60:91-101. [PMID: 34365226 DOI: 10.1016/j.coph.2021.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Misra AC, Eckhoff D. The development of artificial livers. Curr Opin Organ Transplant 2021. [PMID: 34325441 DOI: 10.1097/MOT.0000000000000907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Karvellas CJ, Francoz C, Weiss E. Liver Transplantation in Acute-on-chronic Liver Failure. Transplantation 2021;105:1471-81. [PMID: 33208692 DOI: 10.1097/TP.0000000000003550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
15 Jalan R, D'Amico G, Trebicka J, Moreau R, Angeli P, Arroyo V. New clinical and pathophysiological perspectives defining the trajectory of cirrhosis. J Hepatol 2021;75 Suppl 1:S14-26. [PMID: 34039485 DOI: 10.1016/j.jhep.2021.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
16 Caraceni P, Abraldes JG, Ginès P, Newsome PN, Sarin SK. The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery. J Hepatol 2021;75 Suppl 1:S118-34. [PMID: 34039483 DOI: 10.1016/j.jhep.2021.01.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
17 Bernal W, Karvellas C, Saliba F, Saner FH, Meersseman P. Intensive care management of acute-on-chronic liver failure. J Hepatol 2021;75 Suppl 1:S163-77. [PMID: 34039487 DOI: 10.1016/j.jhep.2020.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Parsons RF, Baquerizo A, Kirchner VA, Malek S, Desai CS, Schenk A, Finger EB, Brennan TV, Parekh KR, MacConmara M, Brayman K, Fair J, Wertheim JA; ASTS Cellular Transplantation Committee. Challenges, highlights, and opportunities in cellular transplantation: A white paper of the current landscape. Am J Transplant 2021. [PMID: 34212485 DOI: 10.1111/ajt.16740] [Reference Citation Analysis]
19 Li WJ, Zhu XJ, Yuan TJ, Wang ZY, Bian ZQ, Jing HS, Shi X, Chen CY, Fu GB, Huang WJ, Shi YP, Liu Q, Zeng M, Zhang HD, Wu HP, Yu WF, Zhai B, Yan HX. An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs. Sci Transl Med 2020;12:eaba5146. [PMID: 32641490 DOI: 10.1126/scitranslmed.aba5146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
20 Thanda Han MA, Pyrsopoulos N. Emerging Therapies for Alcoholic Hepatitis. Clin Liver Dis 2021;25:603-24. [PMID: 34229843 DOI: 10.1016/j.cld.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kumar R, Mehta G, Jalan R. Acute-on-chronic liver failure. Clin Med (Lond). 2020;20:501-504. [PMID: 32934045 DOI: 10.7861/clinmed.2020-0631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
22 German MN, Musto J, Lucey MR. Novel treatments for alcoholic hepatitis. Curr Opin Gastroenterol 2021;37:179-86. [PMID: 33769374 DOI: 10.1097/MOG.0000000000000725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ocskay K, Kanjo A, Gede N, Szakács Z, Pár G, Erőss B, Stange J, Mitzner S, Hegyi P, Molnár Z. Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis. Ann Intensive Care 2021;11:10. [PMID: 33462764 DOI: 10.1186/s13613-020-00795-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
24 Huang D, Gibeley SB, Xu C, Xiao Y, Celik O, Ginsberg HN, Leong KW. Engineering liver microtissues for disease modeling and regenerative medicine. Adv Funct Mater 2020;30:1909553. [PMID: 33390875 DOI: 10.1002/adfm.201909553] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
25 Wencel A, Ciezkowska M, Wisniewska M, Zakrzewska KE, Pijanowska DG, Pluta KD. Effects of genetically modified human skin fibroblasts, stably overexpressing hepatocyte growth factor, on hepatic functions of cocultured C3A cells. Biotechnol Bioeng 2021;118:72-81. [PMID: 32880912 DOI: 10.1002/bit.27551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Tornai D, Szabo G. Emerging medical therapies for severe alcoholic hepatitis. Clin Mol Hepatol 2020;26:686-96. [PMID: 32981291 DOI: 10.3350/cmh.2020.0145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
27 Arshad A, Irshad L, Nabavi T, Whitehouse T. Acute-on-chronic liver failure: to admit to intensive care or not? Br J Hosp Med (Lond) 2020;81:1-6. [PMID: 32990068 DOI: 10.12968/hmed.2020.0310] [Reference Citation Analysis]
28 Singal AK, Shah VH. Current trials and novel therapeutic targets for alcoholic hepatitis. J Hepatol 2019;70:305-13. [PMID: 30658731 DOI: 10.1016/j.jhep.2018.10.026] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 26.0] [Reference Citation Analysis]
29 Yakubtsevich RE, Grodno State Medical University, Grodno, Belarus. EXTRACORPOREAL BLOOD PURIFICATION IN INTENSIVE THERAPY OF ACUTE LIVER FAILURE. Hepatol Gastroenterol 2020;4:5-11. [DOI: 10.25298/2616-5546-2020-4-1-5-11] [Reference Citation Analysis]
30 Elias ED, Uhanova J, Minuk GY. Serum immunoglobulin A levels and alcohol-induced liver disease. CanLivJ 2020;3:177-187. [DOI: 10.3138/canlivj.2019-0006] [Reference Citation Analysis]
31 Xu X, Qin B. Extracorporeal liver support in patients with liver failure. Intensive Care Med 2020;46:829-830. [DOI: 10.1007/s00134-020-05928-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Jia Z, Cheng Y, Jiang X, Zhang C, Wang G, Xu J, Li Y, Peng Q, Gao Y. 3D Culture System for Liver Tissue Mimicking Hepatic Plates for Improvement of Human Hepatocyte (C3A) Function and Polarity. Biomed Res Int 2020;2020:6354183. [PMID: 32190673 DOI: 10.1155/2020/6354183] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
33 Huber W, Ruiz de Garibay AP. Options in extracorporeal support of multiple organ failure. Med Klin Intensivmed Notfmed 2020;115:28-36. [PMID: 32095838 DOI: 10.1007/s00063-020-00658-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
34 Cernigliaro V, Peluso R, Zedda B, Silengo L, Tolosano E, Pellicano R, Altruda F, Fagoonee S. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cells 2020;9:E386. [PMID: 32046114 DOI: 10.3390/cells9020386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
35 Kojima H, Nakamura K, Kupiec-Weglinski JW. Therapeutic targets for liver regeneration after acute severe injury: a preclinical overview. Expert Opin Ther Targets 2020;24:13-24. [PMID: 31906729 DOI: 10.1080/14728222.2020.1712361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Rice JP. Acute Alcoholic Hepatitis. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_10] [Reference Citation Analysis]
37 Pluta KD, Samluk A, Wencel A, Zakrzewska KE, Gora M, Burzynska B, Ciezkowska M, Motyl J, Pijanowska DG. Genetically modified C3A cells with restored urea cycle for improved bioartificial liver. Biocybernetics and Biomedical Engineering 2020;40:378-87. [DOI: 10.1016/j.bbe.2019.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Patel P, Pyrsopoulos NT. Extracorporeal Cellular Liver Assisted Devices. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_67] [Reference Citation Analysis]
39 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [PMID: 31314133 DOI: 10.1002/hep.30866] [Cited by in Crossref: 231] [Cited by in F6Publishing: 247] [Article Influence: 115.5] [Reference Citation Analysis]
40 Stange J. Cellular and Non-Cellular Liver Assist Devices in Management of Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Brumer R, Navabi S, Pyrsopoulos N. Looking Past Orthotopic Liver Transplantation: A Review of Emerging Strategies for Managing Acute and Acute-on-Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_17] [Reference Citation Analysis]
42 Testino G, Vignoli T, Patussi V, Scafato E, Caputo F; SIA board (Appendix A) and the external expert supervisors (Appendix B). Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA). Dig Liver Dis 2020;52:21-32. [PMID: 31757596 DOI: 10.1016/j.dld.2019.09.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
43 Li ZH, Xie ZY, Ouyang XX, Huang KZ, Yu XP, Zhao YL, Zhang YH, Zhu DH, Yu J, Li LJ. Assessment of biological functions for C3A cells interacting with adverse environments of liver failure plasma. Hepatobiliary Pancreat Dis Int 2020;19:129-37. [PMID: 31704080 DOI: 10.1016/j.hbpd.2019.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Chamuleau RAFM, Hoekstra R. End-stage liver failure: filling the treatment gap at the intensive care unit. J Artif Organs 2020;23:113-23. [PMID: 31535298 DOI: 10.1007/s10047-019-01133-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
45 Kabbani AR, Tergast TL, Manns MP, Maasoumy B. [Treatment strategies for acute-on-chronic liver failure]. Med Klin Intensivmed Notfmed 2021;116:3-16. [PMID: 31463674 DOI: 10.1007/s00063-019-00613-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Philips CA, Augustine P, Yerol PK, Rajesh S, Mahadevan P. Severe alcoholic hepatitis: current perspectives. Hepat Med. 2019;11:97-108. [PMID: 31496843 DOI: 10.2147/hmer.s197933] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
47 Wong VW, Singal AK. Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis. Transl Gastroenterol Hepatol. 2019;4:53. [PMID: 31463412 DOI: 10.21037/tgh.2019.06.06] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
48 Veryan J, Forrest EH. Recent advances in alcoholic hepatitis. Frontline Gastroenterol 2020;11:133-9. [PMID: 32133112 DOI: 10.1136/flgastro-2018-101104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Lee BP, Terrault NA. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transplant 2018;23:229-36. [PMID: 29389821 DOI: 10.1097/MOT.0000000000000507] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
50 Bräsen JH, Mederacke YS, Schmitz J, Diahovets K, Khalifa A, Hartleben B, Person F, Wiech T, Steenbergen E, Großhennig A, Manns MP, Schmitt R, Mederacke I. Cholemic Nephropathy Causes Acute Kidney Injury and Is Accompanied by Loss of Aquaporin 2 in Collecting Ducts. Hepatology 2019;69:2107-19. [PMID: 30633816 DOI: 10.1002/hep.30499] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
51 Wu T, Morgan TR, Klein AS, Volk ML, Saab S, Sundaram V. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol 2018;17:759-68. [PMID: 30145578 DOI: 10.5604/01.3001.0012.3134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
52 Shipley LC, Kodali S, Singal AK. Recent updates on alcoholic hepatitis. Dig Liver Dis 2019;51:761-8. [PMID: 31010745 DOI: 10.1016/j.dld.2019.03.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
53 Larsen FS. Artificial liver support in acute and acute-on-chronic liver failure: . Current Opinion in Critical Care 2019;25:187-91. [DOI: 10.1097/mcc.0000000000000584] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]
54 Kandiah PA, Subramanian RM. Extracorporeal Devices. Crit Care Clin 2019;35:135-50. [PMID: 30447776 DOI: 10.1016/j.ccc.2018.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
55 Villarreal JA, Sussman NL. Extracorporeal Liver Support in Patients with Acute Liver Failure. Tex Heart Inst J 2019;46:67-8. [PMID: 30833847 DOI: 10.14503/THIJ-18-6744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Blau BJ, Miki T. The role of cellular interactions in the induction of hepatocyte polarity and functional maturation in stem cell-derived hepatic cells. Differentiation. 2019;106:42-48. [PMID: 30878880 DOI: 10.1016/j.diff.2019.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
57 Yarustovsky MB, Abramyan MV, Komardina EV. Effectiveness of extracorporeal hemocorrection methods in intensive therapy of liver failure. Anesteziologiya i Reanimatologiya 2019. [DOI: 10.17116/anaesthesiology201906165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Ohashi K, Pimienta M, Seki E. Alcoholic liver disease: A current molecular and clinical perspective. Liver Res. 2018;2:161-172. [PMID: 31214376 DOI: 10.1016/j.livres.2018.11.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
59 Nguyen-khac E, Dejour V, Sarba R, Yzet T, Turpin J, Chatelain D, Marcq I, Chivot C, Maizel J, Papillon C, Attencourt C, Houchi H. Hépatite alcoolique aiguë sévère. Méd Intensive Réa 2018;27:510-521. [DOI: 10.3166/rea-2018-0069] [Reference Citation Analysis]
60 Im GY. Acute Alcoholic Hepatitis. Clin Liver Dis 2019;23:81-98. [PMID: 30454835 DOI: 10.1016/j.cld.2018.09.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
61 Thompson JA, Martinson N, Martinson M. Mortality and costs associated with alcoholic hepatitis: A claims analysis of a commercially insured population. Alcohol 2018;71:57-63. [PMID: 30048829 DOI: 10.1016/j.alcohol.2018.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
62 Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4:16. [PMID: 30115921 DOI: 10.1038/s41572-018-0014-7] [Cited by in Crossref: 348] [Cited by in F6Publishing: 382] [Article Influence: 87.0] [Reference Citation Analysis]
63 Huang Y, Peng Q, Li HY, Jia ZD, Li Y, Gao Y. Novel sericin-based hepatocyte serum-free medium and sericin’s effect on hepatocyte transcriptome. World J Gastroenterol 2018; 24(30): 3398-3413 [PMID: 30122879 DOI: 10.3748/wjg.v24.i30.3398] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
64 Nguyen-khac E, Dejour V, Sarba R, Yzet T, Chatelain D, Marcq I, Chivot C, Papillon CA, Attencourt C, Houchi H. Hépatite alcoolique aiguë sévère. La Presse Médicale 2018;47:655-666. [DOI: 10.1016/j.lpm.2018.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Ma M, Falloon K, Chen PH, Saberi B, Pustavoitau A, Ozdogan E, Li Z, Philosophe B, Cameron AM, Gurakar A. The Role of Liver Transplantation in Alcoholic Hepatitis. J Intensive Care Med 2019;34:277-91. [PMID: 29879862 DOI: 10.1177/0885066618780339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
66 Garnier D, Li R, Delbos F, Fourrier A, Collet C, Guguen-Guillouzo C, Chesné C, Nguyen TH. Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system. Sci Rep 2018;8:8222. [PMID: 29844473 DOI: 10.1038/s41598-018-26584-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
67 Sussman NL, Kelly JH. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl 2018;24:711. [PMID: 29385313 DOI: 10.1002/lt.25026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Morgan T. Extracorporeal liver assist device for alcoholic hepatitis: A potential silver lining? Liver Transpl 2018;24:330-2. [DOI: 10.1002/lt.25020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]